| Period Ending: |
LTM
(Last Twelve Months) |
2021 12-31 |
2020 12-31 |
|---|---|---|---|
| Report Filing | 2022-08-12 | 2022-03-29 | 2021-03-31 |
| Revenue | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 |
| Operating Expenses | 411.3 | 1.37 | 0.336 |
| Research & Development | 0 | 0 | 0 |
| Selling, General and Administrative | 411.2 | 1.25 | 0.307 |
| Other Operating Expenses | 0.12 | 0.12 | 0.029 |
| Operating Income | -411.3 | -1.37 | -0.336 |
| Net Non-Operating Interest | 412.7 | 4.02 | 0 |
| Interest Income | 0 | 0 | 0 |
| Interest Expense | -412.7 | -4.02 | 0 |
| Equity & Other Income/(Expense) | 0.797 | 0 | 0 |
| Income Before Tax | 2.16 | 2.65 | -0.336 |
| Income Tax Expense | -412.7 | -4.02 | 0 |
| Income Attributable to Non-Controlling Interest | 0 | 0 | 0 |
| Net Income | 414.8 | 6.68 | -0.336 |
| Depreciation and Amortization | 413.5 | 4.02 | 0.206 |
| EBITDA | 2.16 | 2.65 | -0.13 |
| Earnings Per Share (EPS) | 32.87 | 0.53 | -0.027 |
| Diluted Earnings Per Share | 32.87 | 0.53 | -0.027 |
| Weighted Average Shares Outstanding | 10.19 | 12.63 | 12.63 |
| Diluted Weighted Average Shares Outstanding | 10.19 | 12.63 | 12.63 |
